首页|清肺解毒方联合哌拉西林钠他唑巴坦钠在重症肺炎痰热壅肺证治疗中的应用

清肺解毒方联合哌拉西林钠他唑巴坦钠在重症肺炎痰热壅肺证治疗中的应用

扫码查看
目的 观察清肺解毒方联合哌拉西林钠他唑巴坦钠在重症肺炎痰热壅肺证治疗中的应用效果。方法 前瞻性选取2020年7月-2022年7月医院收治的重症肺炎痰热壅肺证患者为研究对象,按照随机数字表法分为对照组和试验组。对照组给予哌拉西林钠他唑巴坦钠治疗,试验组采取哌拉西林钠他唑巴坦钠联合清肺解毒方治疗,均持续治疗14 d。比较两组治疗效果、中医症候(发热、咳嗽、痰壅、喘息)积分、炎症标志物(降钙素原[PCT]、白细胞介素-6[IL-6]水平)、血气分析指标(氧分压[PaO2]、氧合指数[OI])水平及不良反应发生。结果 治疗后,试验组总有效率高于对照组(P<0。05)。治疗14 d后,两组中医症候积分均低于治疗前,试验组低于对照组(P<0。05);两组PCT、1L-6均低于治疗前,试验组低于对照组(P<0。05);两组PaO2、OI水平均高于治疗前,试验组高于对照组(P<0。05)。治疗期间,两组不良反应发生率比较,差异无统计学意义(P>0。05)。结论 清肺解毒方联合哌拉西林钠他唑巴坦钠治疗重症肺炎痰热壅肺证疗效良好,可明显抑制炎症反应,改善患者临床症状及呼吸功能。
Application of Qingfei Jiedu Formula(清肺解毒方)Combined with Piperacillin Sodium and Tazobactam Sodium in the Treatment Of Severe Pneumonia with Phlegm Heat Obstructing Lung Syndrome
Objective To observe the application effect of Qingfei Jiedu Formula(清肺解毒方)combined with piperacillin so-dium and tazobactam sodium in the treatment of severe pneumonia with phlegm heat obstructing lung syndrome.Method A pro-spective study was conducted on patients with severe pneumonia with phlegm heat obstructing lung syndrome admitted to the hos-pital from July 2020 to July 2022.They were divided into a control group and a study group using a random number table meth-od.The control group was treated with piperacillin sodium and tazobactam sodium,while the study group was treated with pip-eracillin sodium and tazobactam sodium combined with Qingfei Jiedu Formula,both of which continued for 14 days.The treat-ment effect,traditional Chinese medicine symptom(fever,cough,phlegm obstruction,wheezing)scores,levels of inflammatory markers[pro Calcitonin(PCT),interleukin-6(IL-6)],blood gas analysis indicators[Oxygen partial pressure(PaO2),oxy-genation index(OI)]and adverse reactions were compared between the two groups.Result After treatment,the total effective rate of the study group was higher than that of the control group(P<0.05).After 14 days of treatment,the traditional Chinese medicine symptom scores of both groups of patients were lower than before treatment,and the study group was lower than the con-trol group(P<0.05).The PCT and IL-6 levels in both groups of patients were lower than before treatment,and the study group was lower than the control group(P<0.05).The levels of PaO2 and OI in both groups of patients were higher than before treatment,and the study group was higher than the control group,with a statistical significant difference(P<0.05).During the treatment period,there was no statistical significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The combination of Qingfei Jiedu Formula and piperacillin sodium and tazobactam sodium has a good thera-peutic effect on severe pneumonia with phlegm heat obstructing lung syndrome.It can significantly inhibit inflammatory reactions,improve clinical symptoms and respiratory function of patients.

severe pneumoniaphlegm heat obstructing lung syndromeQingfei Jiedu Formula(清肺解毒方)piperacillin sodium and tazobactam sodium

郝丽丽、郭敏

展开 >

北京中医药大学东直门医院洛阳医院,河南洛阳 471000

重症肺炎 痰热壅肺证 清肺解毒方 哌拉西林钠他唑巴坦钠

2024

实用中医内科杂志
辽宁省中医药学会,中华中医药学会,辽宁省中医药研究院

实用中医内科杂志

影响因子:0.421
ISSN:1671-7813
年,卷(期):2024.38(11)